| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 3. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | sodium fusidate (Sodium Fusidate for Intravenous Infusion) |
| Formulation | 500 mg powder for solution for infusion |
| Reference number | 3460 |
| Indication | Treatment of all staphylococcal infections due to susceptible organisms such as: osteomyelitis, pneumonia, septicaemia, wound infections, endocarditis, superinfected cystic fibrosis, cutaneous infections |
| Company | Essential Pharma Ltd |
| BNF chapter | Infections |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 21/03/2017 |